August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness BIOLOGICAL AGENTS.

Slides:



Advertisements
Similar presentations
Responding to the Threat of Bioterrorism: A Status Report on Vaccine Research in the United States Good Morning. Over the next 1 ½ hours of so I’ll be.
Advertisements

Smallpox Vaccine: Overview for Health Care Response Teams
BW Agents: Anthrax J.A. Sliman, MD, MPH LCDR MC(FS) USN Preventive Medicine Resident Johns Hopkins Bloomberg School of Public Health.
BIOLOGICAL AGENTS  CDC has prioritized them in Lists A - C  A List:  Easily transmitted/disseminated  High mortality rate  Potential for public panic.
By: Samantha Hatfield & Rachel Irwing. A severe lung infection that affects humans and animals.
Bioterrorist Agents: Tularemia
Decontamination During Human Biological Incidents Presented by The Ohio Department of Health Disaster Preparedness & Response Program.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
ANTHRAX By: Justin Tursellino. Anthrax is a…. Anthrax is an infection caused by a bacterium, Bacillus anthracis. The infection can take three forms depending.
THE BLACK PLAGUE. The Italian writer Boccaccio said the Plague’s victims often… "ate lunch with their friends and dinner with their ancestors in paradise."
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
Standardized Awareness Authorized Training, Train-the-Trainer Biological Agents.
Bloodborne Pathogens HIV, AIDS, and Hepatitis Unit 1.
بسم الله الرحمن الرحيم. EXPANDED PROGRAMM OF IMMUNIZATION VisitAge Vaccine DiseaseDoseRouteSite 1At Birth BCG Tuberculosis0.05ml1/dRight deltoid OPV zero.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Ohio Department of Health1 The State of Ohio Weapons of Mass Destruction BIO TERRORISM PROTOCOL PROCEDURES FOR LOCAL, STATE AND FEDERAL PERSONNEL AND AGENCIES.
Topic : Ebola Fever Name : Muhammad Habib Bin Ismail Period : 3rd H/R : A642.
Terry Kotrla, MS, MT(ASCP)BB
VIRUSES: Alive or Not?.
Ricinus Communis Toxic Plants.
Smallpox By Amber, Jacob, And Olivia. Smallpox is a serious and contagious disease that causes a rash on the skin.
Unit B10-5 Animal Science and the Industry. Problem Area 10 Veterinary Science.
Vibrio cholerae Asiatic or Epidemic Cholera. Readings Question #1 Describe the Vibrio cholerae bacterium. Where is it found?
Approved: 9 Jun DoD Leader’s Briefing: Force Health Protection Against Anthrax.
EBOLA HAEMORRHAGIC FEVER – BLEEDING FEVER 7NEWS EBOLA UPDATE.
DISASTER PREPAREDNESS.  Definition:  Any situation/event that overwhelms existing resources or ability to respond.
1 Biological Agents Slides will automatically advance seconds after clicking on start button.
SMALL POX By: Harrison Keyes. WHAT Small pox, know as Variola Major and Variola Minor to the latins. Small pox can be found in small blood vessels of.
Factors That Influence Epidemics Transmission and The Role of Nurses in the Identification of an Epidemic.
DISASTER PREPAREDNESS.  Definition:  Any situation/event that overwhelms existing resources or ability to respond.
Response to Terrorism and Weapons of Mass Destruction Chapter 38.
By: Makayla Claiborne and Amber Howard SMALLPOX. What is Smallpox? Smallpox also called variola is defined as an acute infectious disease, meaning that.
Outbreaks and Epidemics Ebola Hemorrhagic Fever. Ebola facts and origins  Ebola hemorrhagic fever is a severe, often-fatal disease in humans and nonhuman.
CHICKEN POX&SMALL POX Edited by: Dr: HALA ALI ABED Lecturer of public health.
Definitions Learning Objectives At the end of this lecture you (will) be able to: Understand definitions used in infectious disease epidemiology.
The Killer Spore Anthrax Sara Bornstein. Bacillus Anthracis Anthrax is a bacteria, with a few specific characteristics: Anthrax has a thick outer capsule,
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
HEPATITIS A EISENMAN ARIE, M.D Department of Internal Medicine B Rambam Medical Center Haifa, Israel
Chicken Pox.
CHAPTER 46 Immunizing Drugs and Biochemical Terrorism 1/7/20161Winter 2013.
(insert screaming now)
Dr. Fredda Branyon My life's mission is to educate people about the power of HOPE.
August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness RADIOLOGICAL NUCLEAR EXPLOSIVE.
Bioterrorism Agents Epidemiology Program Overview.
Varicella & Pregnancy Dr S. Asadi Infectious diseases specialist
Section 3: Bacteria, Viruses, and Humans
Prevention & Control of Infectious Diseases
Vaccines.
Infection Control and Standard Precautions
Chicken pox.
The Chain of Infection.
RADIOLOGICAL NUCLEAR EXPLOSIVE
Biological agents that might be used as weapons of Bioterrorism
Microbes and Disease.
EBOLA VIRUS DISEASE Joseph P. Iser, MD, DrPH, MSc Southern Nevada Health District.
Bioterrorism.
Chapter 4 Hazards.
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
CHAPTER 40 THE IMMUNE SYSTEM AND DISEASE
BW Agents: Plague J.A. Sliman, MD, MPH LCDR MC(FS) USN
Presentation transcript:

August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness BIOLOGICAL AGENTS

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS Objectives Identify indicators that may cause the EMS provider to suspect a biological incident Identify indicators that may cause the EMS provider to suspect a biological incident Identify signs, symptoms and management of common biological diseases Identify signs, symptoms and management of common biological diseases Ensure adequate protection for EMS providers in a biological incident Ensure adequate protection for EMS providers in a biological incident

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS A deliberate release of germs or other biological substances that can make people sick Usually enter the body through inhalation or ingestion. Absorption and injection is possible but less likely means of entry The initial response will most likely be made by direct patient care providers and the public health community

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS Unlike with chemical attacks, there may be a delay between exposure and onset of illness Incubation period is characteristic of infectious disease. The incubation period can range from several hours to several weeks depending on the agent (pathogen) and the exposure

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS Victims may spread the disease prior to learning they have been infected Some biological agents do not cause contagious diseases (Anthrax) Some are highly contagious (Smallpox)

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS Terrorism Advantages Easy to make Easy to make Available Available Cheap Cheap Hard to detect Hard to detect Easily spread Easily spread Tie up resources Tie up resources Psychological impact Psychological impact Difficult to prepare for Difficult to prepare forDisadvantages Delayed effects Production hazardous

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS Indicators of Possible Biological Agent Use A biological hazard may be recognized by: Identification of a credible threat Identification of a credible threat Discovery of bioterrorism evidence such as devices, agents, or a lab Discovery of bioterrorism evidence such as devices, agents, or a lab Non-traumatic multiple casualty incident Non-traumatic multiple casualty incident

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS Categories of Biological Agents

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness Photo courtesy of the Tropical Medicine Institute, UPCH Anthrax

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness ANTHRAX Prophylaxis: A licensed vaccine for use in those considered to be at risk of exposure. A licensed vaccine for use in those considered to be at risk of exposure. Vaccine schedule is 0, 2, and 4 weeks for the initial series, followed by boosters at 6, 12, and 18 months and then a yearly booster. Vaccine schedule is 0, 2, and 4 weeks for the initial series, followed by boosters at 6, 12, and 18 months and then a yearly booster. Oral ciprofloxacin may be used for known or imminent exposure. Oral ciprofloxacin may be used for known or imminent exposure.Decontamination: Secretion and lesion precautions should be practiced. Secretion and lesion precautions should be practiced. After an invasive procedure or autopsy is performed, the instruments and area used should be thoroughly disinfected with a sporicidal agent (iodine or chlorine). After an invasive procedure or autopsy is performed, the instruments and area used should be thoroughly disinfected with a sporicidal agent (iodine or chlorine).

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness PLAGUE The pneumonic form of the disease would be seen as the primary form after purposeful aerosol dissemination of the organisms. The bubonic form would be seen after purposeful dissemination through the release of infected fleas.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness PLAGUE All human populations are susceptible. Recovery from the disease may be followed by temporary immunity. The organism will probably remain viable in water and moist meals and grains for several weeks.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness PLAGUE Treatment: Early administration of antibiotics is very effective. Early administration of antibiotics is very effective. Supportive therapy for pneumonic and septicemic forms is required. Supportive therapy for pneumonic and septicemic forms is required.Prophylaxis: A licensed, killed vaccine is available. Initial dose followed by a second smaller dose 1-3 months later, and a third 3-6 months later. A licensed, killed vaccine is available. Initial dose followed by a second smaller dose 1-3 months later, and a third 3-6 months later. A booster dose is given at 6, 12 and 18 months and then every 1-2 years. A booster dose is given at 6, 12 and 18 months and then every 1-2 years. This vaccine may not protect against aerosol exposure. This vaccine may not protect against aerosol exposure.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness PLAGUE Decontamination and Isolation: Secretion and lesion precautions with bubonic plague. Secretion and lesion precautions with bubonic plague. Strict isolation of patients with pneumonic plague is required. Strict isolation of patients with pneumonic plague is required. Heat, disinfectants and exposure to sunlight renders bacteria harmless. Heat, disinfectants and exposure to sunlight renders bacteria harmless.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness TULAREMIA Signs and Symptoms: Ulceroglandular tularemia presents with a local ulcer and regional lymphadenopathy Ulceroglandular tularemia presents with a local ulcer and regional lymphadenopathyFeverChillsHeadacheMalaise.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness TULAREMIA Treatment: Administration of antibiotics (streptomycin or gentamicin) with early treatment is very effective. Administration of antibiotics (streptomycin or gentamicin) with early treatment is very effective.Prophylaxis: A live, attenuated vaccine is available as an investigational new drug. A live, attenuated vaccine is available as an investigational new drug. It is administered once by scarification. A two week course of tetracycline is effective as prophylaxis when given after exposure.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS VIRUSES Viruses are the simplest type of microorganisms. They depend upon living cells to multiply, so a virus will not live long outside of a host. Dengue Fever Dengue Fever Equine Encephalitis Equine Encephalitis Variola Variola Ebola Ebola Smallpox Smallpox

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness SMALL POX Variola virus is the cause of smallpox. It is an Orthopox virus and occurs in at least two strains, one of which causes variola major, and the other causes a milder disease, variola minor. Despite widespread availability of a vaccine, the potential weaponization of variola continues to pose a military threat. This threat can be attributed to the aerosol infectivity of the virus, the relative ease of large-scale production, and an increasingly Orthopoxvirus-naive populace.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness SMALL POX Although the fully-developed cutaneous eruption of smallpox is unique, earlier stages of the rash could be mistaken for varicella. Secondary spread of infection constitutes a nosocomial hazard from the time of onset of a smallpox patient's exanthem until scabs have separated. Quarantine with respiratory isolation should be applied to secondary contacts for 17 days post- exposure.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness SMALL POX Signs and Symptoms: The incubation period of smallpox averages 12 days, and contacts are quarantined for a minimum of days following exposure. The incubation period of smallpox averages 12 days, and contacts are quarantined for a minimum of days following exposure. Clinical manifestations begin acutely with malaise, fever, rigors, vomiting, headache, and backache. Clinical manifestations begin acutely with malaise, fever, rigors, vomiting, headache, and backache. 2-3 days later lesions appear which quickly progress from macules to papules, and eventually to pustular vesicles. 2-3 days later lesions appear which quickly progress from macules to papules, and eventually to pustular vesicles. They are more abundant on the extremities and face, and develop synchronously.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness SMALL POX

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness SMALL POX Isolation: Strict quarantine with respiratory isolation for a minimum of days following exposure for all contacts. Strict quarantine with respiratory isolation for a minimum of days following exposure for all contacts. Patients should be considered infectious until all scabs separate. Patients should be considered infectious until all scabs separate.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness BIOLOGICAL AGENTS TOXINS Toxins are toxic substances of natural origin produced by an animal, plant or microbe. They differ from chemical agents in that they are not manmade and are much more complex materials. They are usually more toxic than many chemical agents. Botulinum Botulinum Perfringens Perfringens Ricin Ricin Saxitoxin Saxitoxin Mycototoxins Mycototoxins

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness RICIN The symptoms of human poisoning begin within a few hours of ingestion. The symptoms are: abdominal pain vomiting diarrhea, sometimes bloody. Within several days there is: severe dehydration, a decrease in urine, and a decrease in blood pressure. Treatment Supportive care Supportive care

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness RICIN Just one milligram of Ricin can kill an adult Just one milligram of Ricin can kill an adult If death has not occurred in 3-5 days, the victim usually recovers.

August 2005 EMS & Trauma Systems Section Office of public Health Preparedness Maintain awareness for contagious/ infectious diseases Utilize appropriate PPE Prophylaxis may be necessary Biological Agents develops over days vs minutes.